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Cardiogenesis requires the generation of
endothelial, cardiac, and smooth muscle cells,
thought to arise fromdistinct embryonic precur-
sors. We use genetic fate-mapping studies to
document that isl1+ precursors from the second
heart field can generate each of these diverse
cardiovascular cell types in vivo. Utilizing em-
bryonic stem (ES) cells, we clonally amplified
a cellular hierarchy of isl1+ cardiovascular pro-
genitors, which resemble the developmental
precursors in the embryonic heart. The tran-
scriptional signature of isl1+/Nkx2.5+/flk1+ de-
fines a multipotent cardiovascular progenitor,
which can give rise to cells of all three lineages.
These studies document a developmental para-
digm for cardiogenesis, where muscle and en-
dothelial lineage diversification arises from a
single cell-level decision of a multipotent isl1+
cardiovascular progenitor cell (MICP). The dis-
covery of ES cell-derived MICPs suggests a
strategy for cardiovascular tissue regeneration
via their isolation, renewal, anddirecteddifferen-
tiation into specific mature cardiac, pacemaker,
smooth muscle, and endothelial cell types.
INTRODUCTION
The formation of cardiac, smooth muscle, and endothelial
cell lineages in the heart has largely been ascribed to a setCell 1of nonoverlapping embryonic precursors derived from
distinct origins. Cardiac neural crest, the proepicardium,
and the cardiac progenitors of the two heart fields are
thought to follow separate parallel pathways for sequential
lineage maturation (Mikawa and Gourdie, 1996; Manner
et al., 2001; Waldo et al., 2001; Kelly and Buckingham,
2002; Stoller and Epstein, 2005). The discovery of several
heart lineage-restricted genes suggests that the genera-
tion of different cardiac cell types might be driven by a
unique combinatorial subset of transcriptional networks
operating within distinct cardiovascular precursors (for
review, see Srivastava and Olson, 2000). Nevertheless,
an alternative possibility exists that diverse muscle and
nonmuscle lineages arise from a single cell-level decision
of multipotent, primordial cardiovascular stem cells, which
in turn give rise to a hierarchy of downstream cellular inter-
mediates representing tissue-restricted precursors for the
fully differentiated heart cells. This clonal model of heart-
lineage diversification would be analogous to hematopoie-
sis, in which a single hematopoietic stem cell can generate
all of the blood-cell lineages (Morrison and Weissman,
1994; Weissman, 2000).
The recent identification of a second source of embry-
onic myocardial precursors has begun to modify the
classical view of heart formation (Mjaatvedt et al., 2001;
Waldo et al., 2001). The LIM-homeobox transcription
factor islet-1 (isl1) delineates this second cardiogenic pro-
genitor field (Cai et al., 2003; Laugwitz et al., 2005). In this
regard, we have recently reported that after birth the
mammalian heart harbors a rare subset of isl1+ precursors
in the atria, outflow tract, and right ventricle. The postnatal
isl1+ murine cells can be renewed on cardiac mesenchy-
mal feeder layers and triggered into fully differentiated
muscle cells, thereby fulfilling the criteria for endogenous27, 1151–1165, December 15, 2006 ª2006 Elsevier Inc. 1151
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cardioblasts that are developmental remnants of the sec-
ond heart field lineage (Laugwitz et al., 2005). Fate-map-
ping experiments have demonstrated that isl1 and
Nkx2.5 can mark cell populations that contribute to myo-
cardial cells, subsets of endocardium, and aortic endothe-
lium (Cai et al., 2003; Stanley et al., 2002). Furthermore,
Cre-mediated lineage tracing of flk1+ cells have shown
that both vascular endothelium and cardiac muscle arise
from flk1+ mesodermal progenitors during development
(Motoike et al., 2003; Coultas et al., 2005). In both murine
and avian systems, the smooth muscle layer of the proxi-
mal outflow tract originates from the second heart field
lineage, while only the more distal regions of the aorta
and pulmonary artery are derived from cardiac neural
crest (Waldo et al., 2005; Verzi et al., 2005). Thus, there
is a possibility that isl1 marks a multipotent primordial car-
diovascular progenitor, which gives rise to distinct cell
lineages within the heart components known to originate
from the second cardiogenic field (Buckingham et al.,
2005).
Herein, by employing genetic fate-mapping tech-
niques, we identify a subset of primordial multipotent
isl1+ cardiovascular progenitors (MICPs), which can in-
deed generate diverse cardiovascular cell types during
in vivo embryonic heart development. The transcriptional
signature of isl1+/Nkx2.5+/flk1+ defines embryonic stem
(ES) cell-derived cardiovascular precursors, which are
multipotent and give rise to cardiac muscle, smooth mus-
cle, and endothelial cells in vitro. Analogous triple-posi-
tive and dual-positive progenitors were identified in the
developing embryo in vivo, which can be clonally ampli-
fied and differentiated similar to the ES cell-derived
MICPs. These studies report the discovery of a novel
subset of multipotent, embryonic isl1+ progenitors that
contribute to a majority of muscle cells and a subset of
nonmuscle cells in the heart and suggest a new paradigm
for cardiogenesis employing similar principles of stem/
progenitor cell hierarchies as the hematopoietic system.
Since MICPs can be isolated and selectively expanded
from a renewable ES cell-based source, the findings point
to a new strategy for cardiovascular tissue regeneration
via the directed differentiation of ES cell-based MICPs
into discrete cardiac, pacemaker, smooth muscle, and
endothelial cell lineages.Cell 1RESULTS
isl1+ Cells of the Second Heart Field Contribute
to Smooth Muscle, Endothelial, Pacemaker,
and other Nonmuscle Cell Lineages
in the Postnatal Heart
In this study, we used isl1-IRES-Cre/R26R double-hetero-
zygous animals to define the contribution of isl1+ precur-
sors to other cardiac lineages besides myocytes in the
postnatal and adult heart (Figure 1). Histochemical analysis
of b-galactosidase (b-gal) and acetylcholinesterase (Ach-
esterase) activities revealed a remarkable contribution of
isl1+ progenitors to the sino-atrial (SA) node (Figure 1A),
while only a few cells of the atrial-ventricular (AV) node
seem to derive from isl1+ precursors (Figure 1B). Addition-
ally, b-gal expression was observed throughout the proxi-
mal aorta (Figure 1C), the trunk of the pulmonary artery
(Figure 1D), and the stems of the main left and right coro-
nary arteries (Figures 1E and 1F). b-gal+ cells were de-
tected in connective tissue structures of the aortic and
pulmonary valve leaflets (Figures 1G and 1H), thereby indi-
cating that components of the conotruncal cushions,
which have an endocardial origin, are derived from isl1+
progenitors. Coexpression of the genetic marker lacZ
with endothelial and smooth muscle cell specific proteins,
such as CD31, VE-cadherin, and smooth muscle myosin
heavy chain (SM-MHC), demonstrated that isl1+ precur-
sors are capable to give rise to vascular lineages (Fig-
ures 1I and 2) and to cells forming the endocardium, the
endothelial cell lining of the heart, in vivo (Figure 1K). To
examine isl1-IRES-Cre-directed lacZ expression in vascu-
lar lineages in greater detail, we isolated cells from the
endothelium and muscular layer of the aorta of isl1-IRES-
Cre/R26R double-heterozygous mice and assayed b-gal
directly by immunohistochemistry using an anti-b-gal anti-
body (Figures 2F–2M). Costaining for b-gal and specific
endothelial and smooth muscle markers was observed in
a significant proportion of cells, confirming a contribution
of isl1-expressing cells to endothelial and smooth muscle
lineages during outflow tract development. Although indi-
cations exist that some cells of the endocardium originate
from the second heart field progenitors (Cai et al., 2003;
Verzi et al., 2005), our results represent the first evidence
that vascular endothelium arises from isl1+ precursors.Figure 1. Genetic Marking of Isl1+ Progenitors and Their Progeny via Cre/Lox Technology
Frozen sections of hearts were obtained from isl1-IRES-Cre/R26R adult mice.
(A and B) b-gal (blue) and acetylcholinesterase (Ach-esterase, brown) activities in sections of the sino-atrial (SA) node (A) and the atrioventricular (AV)
node (B) at low and high magnification. Nuclei (red) are counterstained with hematoxylin. RA, right atrium; VCS, vena cava superior.
(C–H) Low and high magnification of sections of the proximal aorta walls (C), the trunk of the pulmonary artery (D), the stems of the main left (E) and
right (F) coronary arteries, and the aortic (G) and pulmonary (H) valves after X-gal staining (blue) and Nuclear Red counterstaining (red).
(I–K) LacZ reporter gene expression (blue) in a heart section showing coronary vessels and endocardium regions at low magnification (J). Higher mag-
nification of a coronary artery portion (I) after X-gal stain (blue, left panel) and immunohistochemical staining on the following section for the endothelial
marker CD31 (red) and the smooth muscle marker SM-MHC (cyan) are shown. Higher magnification of endocardium (K) after X-gal (blue) and CD31
(red) costain (left panel) and immunofluorescence analysis on the following section for CD31 (red) and the cardiac muscle marker cTnT (green) are
shown. In the fluorescence images nuclei are detected by Hoechst 33258 (blue).27, 1151–1165, December 15, 2006 ª2006 Elsevier Inc. 1153
Figure 2. In Vivo Lineage Tracing and Fate Studies of Isolated Endothelial and Smooth Muscle Cells from Isl1-IRES-Cre/R26R
Double-Heterozygous Mice
Endothelial and mural cells were isolated from aortas of adult mice and maintained for 3 days in culture, prior to b-gal expression and immuno-
histochemical analyses.
(A–E) Representative section of aorta at lower (A) and higher (B) magnification after X-gal stain. High magnification immunofluorescence images of the
following section stained for the endothelial marker CD31 (red, C) and the smooth muscle marker SM-MHC (cyan, D) are shown. Nuclei are detected
by Hoechst 33258 dye.
(F) b-gal+ cluster of isolated endothelial-like cells detected by X-gal stain.
(G–I) Coexpression of b-gal and endothelial markers in isolated aortic cells, assessed by immunofluorescence using anti-b-gal (green, G) and anti-
VE-cadherin (red, H) antibodies. Nuclei were visualized by Hoechst 33258 (blue).
(J) Isolated b-gal+ cells with smooth muscle-like morphology.
(K–M) Coimmunostaining for b-gal (green, K) and SM-MHC (red, L) in isolated aortic cells. Nuclei were labeled with Hoechst 33258 (blue).Cardiac neural crest also contributes to smooth muscle
cells in the more distal regions of the outflow vessels, while
smooth muscle in the proximal outflow tract are derived
from the second heart field lineage (Epstein et al., 2000;
Waldo et al., 2005; Verzi et al., 2005). Coronary vessels
and the epicardium have a common developmental origin
in the proepicardial organ, although its exact extent to the
coronary tree remains to be determined.
A semiquantitative analysis of the in vivo lineage tracing
results is presented in Table S1. Around 80%–90% of right1154 Cell 127, 1151–1165, December 15, 2006 ª2006 Elsevier Iventricular myocardium and 50%–70% of the atria from
double-heterozygous hearts displayed coexpression of
b-gal and specific sarcomeric markers. In the conduction
system the majority of genetically marked cells were de-
tected in the SA nodal region. The contribution of isl1+
cells to the endothelial and smooth muscle cell layers is
limited to the proximal area of the great vessels and pro-
gressively declines from the proximal to the distal parts
of the coronary tree. Our genetic fate-mapping results
clearly demonstrate that isl1 marks a population ofnc.
Figure 3. Cell Fusion-Independent Differentiation of Isl1+ Postnatal Progenitor Cells into the Smooth Muscle Lineage
CMC fractions isolated from isl1-mER-Cre-mER/R26R double-heterozygous hearts were treated with 4-OH-TM and b-gal+ precursors were purified
by FACS sorting at 10 days in culture.
(A) RT-PCR analysis for smooth muscle and progenitor markers in FACS-sorted progenitors (P), neonatal myocytes (M), and smooth muscle cells (SM).
(B) Immunohistochemistry for SM-MHC (brown) after X-gal stain (blue) in coculture of b-gal+ precursors and hca-SMC. Arrows indicate b-gal+ cells
before (1 day coculture) and after (5 days coculture) conversion into SMC. Costain for b-gal and SM-MHC results in a dark olive-green color.
(C) Quantification of differentiation events over time in coculture. Mean values ± SEM from three experiments (n = 1000 cells per group).
(D) Spontaneous conversion of isl+ progenitors into SMC in vitro, assessed by expression of SM-actin (green) and SM-MHC (red) at 5 days in culture.
Nuclei are detected with Hoechst 33528 (blue).
(E) Frequency of spontaneous differentiation of b-gal+ progenitors into SM-MHC-expressing cells over time in culture. Mean values ± SEM from three
experiments (n = 1000 cells per group).
(F) [Ca2+]i measurements after Angiotensin II stimulation in a representative isl1
+ progenitor, which spontaneously converted into an SMC (blue trace)
and in one that did not acquired the SMC phenotype (red trace). Fluorescence images show fluo-4 intensity immediately after Angiotensin II appli-
cation (1.5 s, left panel) and at the peak of the calcium response (66 s, middle panel). Bright field image of the two measured cells (right panel). Circles
indicate the regions of interest used for measuring fluo-4 intensity.precursors, which give rise to a subset of working cardiac
muscle, pacemaker, endothelial, and smooth muscle cells
in multiple heart-tissue compartments.
Spontaneous, Cell Fusion-Independent
Differentiation of Isl1+ Progenitors
into the Smooth Muscle Lineage
To assess the differentiation potential of postnatal isl1+
progenitors into vascular cell lineages, we isolated b-gal+
precursors from isl1-mER-Cre-mER/R26R animals, as
previously described (Laugwitz et al., 2005). After expo-
sure of the culture to 4-hydroxytamoxifen (4-OH-TM) to in-
duce specific marking of isl1-expressing cells, we purifiedCell 1the b-gal+ progenitors by fluorescence-activated cell sort-
ing (FACS) using the fluorogenic b-gal substrate C12FDG,
and performed coculture experiments with low-passage
human coronary artery smooth muscle cells (hca-SMC).
As shown in Figure 3A, FACS-sorted precursors ex-
pressed isl1 and the early specification markers for cardiac
mesoderm, Nkx2.5 and GATA4, while lacking transcripts
of mature smooth muscle cells. After 5 days in coculture,
18% of the b-gal+ cells colabeled with SM-MHC in a
staining pattern similar to that of the hca-SMC (Figures
3B and 3C). Interestingly, even in the absence of the cocul-
ture environment a significant proportion of b-gal+ pro-
genitors converted spontaneously in vitro into functional27, 1151–1165, December 15, 2006 ª2006 Elsevier Inc. 1155
Figure 4. ES Cells as a Source for Isl1+ Cardiac Precursor Cells
(A) Schematic diagram of the isl1 targeted locus in the isl1-nLacZ knockin ES cell line.
(B) Expression analysis of isl1 and other cardiac progenitor markers by RT-PCR in EBs from isl1-nLacZ knockin ES cells at the indicated days of
differentiation.
(C–F) LacZ reporter gene expression assessed by X-gal stain in EBs from isl1-nLacZ knock-in ES cells at days 2 (C), 4 (D), 5 (E), and 6 (F) of differ-
entiation.
(G and H) b-gal activity correlates with isl1 expression in EBs from isl1-nLacZ knockin ES cells. b-gal+ nuclei after X-gal stain (blue, G) costaining for
isl1 protein (green fluorescence, H).
(I) Selective amplification of ES cell-derived isl1+ progenitors on CMC feeder layer. EBs from isl1-nLacZ knockin ES cells were dissociated at 5 days
differentiation and single cells were plated on CMC feeder layer or plastic. b-gal activity was tested at day 1, 3, 5, and 8 on the CMC co-culture and at
day 10 on plastic.
(J) Expression analysis of cardiovascular specification genes in 10 representative clones grown on CMC for 7 days (lanes 1–10) and in control CMC
(last two lanes). Clones can be classified by RT-PCR profile into 4 main groups: isl1+/Nkx2.5+/flk1+ (clones 1–3), isl1+/Nkx2.5+/flk1 (clones 4–6), isl1+/
Nkx2.5/flk1+ (clones 7 and 8), and isl1/Nkx2.5+/flk1 (clones 9 and 10).1156 Cell 127, 1151–1165, December 15, 2006 ª2006 Elsevier Inc.
smooth muscle cells, as demonstrated by the expression
of smooth muscle-specific markers (Figures 3D and 3E)
and by the response to the vasoactive hormone Angoten-
sin II (Figure 3F). In 4 of 25 measured cells, exposure to
Angiotensin II induced a progressive cytosolic [Ca2+]i
increase, which reached the maximum at 70 s and
diminished thereafter, analogous to the agonist-induced
vascular SMC [Ca2+]i transients (Figure 3F).
Thus, postnatal isl1+ cardiac progenitors can adopt the
functional properties of smooth muscle cells in the ab-
sence of cell fusion in vitro. An experimental strategy was
then designed to assess whether single cell-derived
clones of isl1+ progenitors might generate cardiac, smooth
muscle, and endothelial cell lineages.
ES Cells as a Source for Isl1+ Cardiac Precursors
In order to establish an induction and purification system
for cardiac isl1+ precursors from ES cells, we generated
isl1-nlacZ knockin ES cells in which a loxP-flanked nuclear
lacZ gene, followed by hrGFP, was targeted to the geno-
mic isl1 locus (Figure 4A). When allowed to differentiate
in culture, ES cells generate embryoid bodies (EBs) that
contain a broad spectrum of cell types representing deriv-
atives of the three germ layers (Smith, 2001). We analyzed
the time course of isl1 expression in developing EBs from
isl1-nlacZ knockin ES cells by RT-PCR and b-gal staining
(Figures 4B–4F). In undifferentiated ES cells and early
EBs, isl1 expression was not detected on mRNA and
protein level (Figures 4B and 4C). Within 4–6 days of EB
differentiation, ES cell-derived progenitors expressing
isl1 arose, as demonstrated by transcript detection and
b-gal activity (Figures 4B and 4D–4F). Immunohistochem-
istry using a monoclonal anti-isl1 antibody revealed coex-
pression of isl1 and b-gal proteins, indicating that isl1 gene
expression can be monitored by lacZ staining (Figures 4G
and 4H).
ES Cell-Derived Isl1+ Cardiac Progenitors
Can Be Clonally Expanded on Feeder
Layers of Cardiac Mesenchyme
Several markers of early cardiogenic progenitors, includ-
ingNkx2.5,GATA4, andGATA6, continue to be expressed
in differentiated cardiomyocytes and thus do not allow one
to distinguish between progenitors of the crescent stage
and differentiated cardiomyocytes (Buckingham et al.,
2005). Isl1, a cellular marker of the second myocardial
lineage, is downregulated as soon as the cardiac progen-
itors enter a differentiation program. This feature makes it
a suitable marker for isolation of cardiac precursors from
mammalian ES cell systems. However, isl1 is broadly ex-
pressed in many cell lineages during embryogenesisCell 1(Karlsson et al., 1990; Thor et al., 1991). We previously
established a cardiac mesenchyme culture system that
allows the maintenance of isl1 expression in the post-
natal cardiac progenitor population and promotes their
renewal in culture without differentiation (Laugwitz et al.,
2005).
To test whether the mesenchyme environment could
support expansion of isl1+ cardiac precursors arising
during EB differentiation, we dissociated EBs from isl1-
nlacZ knock-in ES cells at day 5 into single cells and plated
them at low density on feeder layers of cardiac mesenchy-
mal cells (CMC) and mouse embryonic fibroblasts (MEFs)
(Figure 4I). After 1 day, we observed single or dividing
b-gal+ cells in the CMC coculture, but none were detected
on MEFs (data not shown). Within 5 days, clones with a
distinct morphology were visible exclusively on top of the
CMC feeders, and around 40% ± 10% presented b-gal
activity in a characteristic focal pattern, reflecting that the
clones originated from a single expanding b-gal+ cell.
Mock treatment by plating dissociated cells from day 5
EBs on plastic or gelatin resulted in attachment and sur-
vival of a small number of cells without any clone formation
(Figure 4I).
Transcriptional profiling of 80 clones following expan-
sion on CMC feeder layers revealed that all of them ex-
press early cardiac specification markers GATA4, Tbx20,
and either isl1 and/or Nkx2.5 (Figure 4J). Interestingly, in
a proportion of isl1-expressing clones we detected the
transcript for flk1. Flk1 is the type-2 receptor for the vascu-
lar endothelial growth factor (VEGF) (Yamaguchi et al.,
1993), and one of the earliest common mesodermal differ-
entiation markers for vascular endothelial and hematopoi-
etic cells (Millauer et al., 1993; Shalaby et al., 1995; Sha-
laby et al., 1997). However, recent evidence suggests
that flk1+ cells also exhibit a differentiation potential for
other mesodermal lineages such as cardiac muscle during
development (Motoike et al., 2003; Ema et al., 2006). Im-
munohistochemical analysis revealed flk1 protein on the
extracellular membrane of single b-gal+ cells growing on
the CMC feeder layers (Figure 4K), suggesting that isl1-
expressing precursors derived from ES cells could have
the potential to differentiate into the endothelial lineage.
After clone expansion, examination of isl1, Nkx2.5, and
flk1 expression demonstrated the existence of subsets of
double-positive cells within a clone: isl1+/flk1+, isl1+/
Nkx2.5+, and flk1+/Nkx2.5+ cells were found in different
proportions depending on the time in culture (Figures 4L–
4U). These results indicate that CMC feeders act as a pre-
specification matrix toward an early cardiac precursor
state and open the possibility to investigate whether the
multipotentiality of isl1+ cardiac progenitors is based on
a single cell-level decision.(K) Immunohistochemistry for flk1 (purple) after X-gal stain (blue) in representative ES cell-derived isl1+ cardiac precursors on CMC at day 2.
(L–U) Representative clones of ES cell-derived cardiac progenitors on CMC at day 6, after immunofluorescence analyses for the transcription factors
isl1 (green) and Nkx2.5 (cyan) and the surface marker flk1 (red). Nuclei are visualized by Hoechst 33528 (blue). A clone containing cells costaining
positively for isl1 and flk1 is shown at 203 (L–O) and at 633magnification (P). Low magnification images (Q–S) of a different clone presenting double
positive isl1/flk1 and Nkx2.5/flk1 cells, which are marked in (R) and shown at 633 in panels (T) and (U).27, 1151–1165, December 15, 2006 ª2006 Elsevier Inc. 1157
Figure 5. Clonal Differentiation Analysis of Cardiac Precursors Derived from Isl1-nLacZ Knockin ES Cells after Expansion on
cardiac CMC
(A) Schematic representation of the experimental procedure used for generating clones of cardiac precursors derived from isl1-nlacZ knockin ES and
for their clonal analysis.
(B–D) RT-PCR profile (B) of a representative progenitor clone, which differentiated into cells expressing the myocytic marker cTnT (green fluores-
cence, C) and the smooth muscle marker SM-MHC (green fluorescence, D).
(E–H) RT-PCR profile (E) of a representative progenitor clone, which differentiated into all the three cardiovascular lineages, giving rise to cells positive
for cTnT (green fluorescence, F), SM-MHC (green fluorescence, G), and VE-cadherin (red fluorescence, H).1158 Cell 127, 1151–1165, December 15, 2006 ª2006 Elsevier Inc.
Clonal Differentiation Analysis of ES Cell-Derived
Cardiac Precursors after Expansion on Cardiac CMC
Cardiac progenitors arising from isl1-nlacZ knockin ES
cells during EB differentiation were clonally expanded on
CMC feeder layers. After 7 days coculture, clones were
picked, dissociated into single cells, and subjected to
gene-expression profiling and differentiation experiments
in vitro (Figure 5A). We tested the differentiation potential
of each clone (n = 207) into the three cardiac lineages:
cardiomyocytes, endothelial cells, and vascular smooth
muscle. After 4 days in specific culture conditions (see
Experimental Procedures), 12% of the clones differenti-
ated into all three lineages, as demonstrated by the ap-
pearance of cells expressing cardiac troponin T (cTnT),
SM-MHC, and VE-cadherin (Figures 5F–5H). In these pro-
genitor clones transcripts of isl1, Nkx2.5, flk1, and/or
CD31,GATA4, and Tbx20were detected (Figure 5E, Table
S2). Two cell lineages originated from30% of the clones,
the most common being cardiomyocytes-SMC (22.7%)
obtained from clones that expressed either Nkx2.5 only
or Nkx2.5/isl1 ± flk1 (Figures 5B–5D, Table S2). All clones
that converted into myocyte-endothelial cells or SMC-
endothelial cells showed expression of isl1 and flk1/CD31
regardless of Nkx2.5 expression. Differentiation into only
one lineage was observed in33% of the clones, the least
abundant being endothelial cells, triggered in clones that
were all positive for isl1, flk1, and Nkx2.5 (Table S2). The
requirement of cells expressing isl1 and flk1/CD31 for
the transition of cardiac progenitor clones into the endo-
thelial lineage was confirmed by analyzing the spontane-
ous differentiation pattern of the isl1-nlacZ knockin ES
cell-derived clones on CMC. By 10 days in coculture, we
observed that a proportion of cells within the clones un-
dergo spontaneous differentiation into myocytes, smooth
muscle, and/or endothelial cells. Cardiac troponin T and
SM-MHC-expressing cells were detected in both b-gal+
and b-gal clones (Figure 5J), while only clones presenting
b-gal activity contained endothelial-like cell structures
staining positively for CD31 or VE-cadherin (Figures 5I
and 5J).
By employing a second independent ES knockin cell
line, in which eGFP is targeted to the Nkx2.5 locus, we
also have documented that ES cell-derived cardiac pro-
genitors can be clonally amplified on CMC feeders and
that Nkx2.5 is sufficient for cardiac and smooth muscle
specification (Supplemental Results, Figure S1).
Taken together, these results suggest that isl1 and flk1/
CD31 expression is important for the conversion of cardiac
precursors intoendothelial cells,whileNkx2.5playsapivotal
role in the specification into the myocytic lineage. Moreover,
our findings indicate that a single ES cell-derived MICP
possesses the potential to serve as ‘‘cardiovascular pro-Cell 1genitor cell’’ in vitro, being able to give rise to cell types of
the working myocardium and the heart vasculature.
Identification, Isolation, and Clonal Amplification
of an Isl1+ Common Precursor for Cardiovascular
Lineages in the Embryo
To establish the existence of MICPs in vivo, we investi-
gated the expression of isl1, Nkx2.5, and flk1 during early
stages of mouse heart development. Immunohisto-
chemical analysis in embryos between ED8.0 and ED8.5
revealed a rare subset of triple positive cardiogenic precur-
sors within splanchnic mesenchyme comprising the mes-
ocardium (Figure 6A). The majority of isl1+ cells detected in
this region coexpressed flk1. In the mesenchyme adjacent
to foregut endoderm, we observed a partially overlapping
expression gradient of isl1 and Nkx2.5, with isl1 being
mainly expressed in splanchnic mesoderm and foregut
endoderm while Nkx2.5 being upregulated in differentiat-
ing myocardial precursors (Figure 6B). Beside the endo-
cardium, flk1 was detected on the membrane of a subset
of Nkx2.5+ cells of the forming heart tube (Figure 6C).
To investigate the differentiation potential of these em-
bryonic cardiac precursors in vitro, we isolated cells
from the heart regions of embryos at ED8.0 and ED8.5
and plated them at low density as single cells on CMC
feeders (Figure 7). Similarly to the ES-derived cardiac
progenitors, the CMC environment allowed the expansion
of the embryonic isolated cells with maintenance of their
cardiac precursor phenotype. Cells coexpressing isl1,
Nkx2.5, and flk1 were detected in small growing clones
after 3–5 days coculture. At this stage the majority of em-
bryo-derived cardiac progenitors displayed double posi-
tivity for two of the three markers, being isl1+/Nkx2.5+,
isl1+/flk1+, or Nkx2.5+/flk1+ (Figure 7A–7D). With increas-
ing time in culture, cells lost flk1 expression, and most of
the clones contained isl1+ and/or Nkx2.5+ precursors
(Figure 7E–7H). Transcriptional profiling and triggered dif-
ferentiation of cells from single clones picked after 7 days
on the CMC showed that 24% (34/144) of the clones main-
tained the potential to convert into both myocytic and
smooth muscle lineages while expressing isl1 and/or
Nkx2.5 (data not shown). Differentiation into smooth mus-
cle cells was observed in 36% of the clones (52/144),
whereas specification into the cardiac muscle lineage
was less abundant (8%, 11/144). Transition into the three
major cardiac cell types (endothelium, myocytes, and
smooth muscle) occurred spontaneously in a rare number
of clones differentiating on the CMC after 10–12 days in
culture (Figure 7I).
Taken together, our findings demonstrate that isl1+/
Nkx2.5+/flk1+ cardiovascular progenitors (MICPs) exist in(I) Immunohistochemical analysis on progenitor clones at 10 days coculture with CMC for CD31 (brown). Blue stain corrisponds to b-gal activity. Inset
represents a magnification of the areas of interest.
(J) Triple immunoperoxidase stain for markers of differentiated endothelial cells (VE-cadherin, purple), cardiomyocytes (cTnT, black), and smooth
muscle cells (SM-MHC, brown) on progenitor clones after X-gal stain (blue) at day 10 on CMC.27, 1151–1165, December 15, 2006 ª2006 Elsevier Inc. 1159
Figure 6. Existence of Isl1+/Nkx2.5+/flk1+ Cardiac Precursors in the Developing Embryo In Vivo
Immunofluorescence analysis for the transcription factors isl1 (green) and Nkx2.5 (cyan) and the surface marker flk1 (red) in transverse cryosections
of embryos at ED8.25. Sections correspond to the position indicated by the lines drawn through the adjacent embryo view and are shown at 203
magnification in the small left panels and at 633 magnification of the area of interest in the big panels.
(A) Triple-positive cells in splanchnic mesoderm are indicated by white arrows.
(B) Yellow arrows mark double isl1/flk1-labeled cells and green arrows cells of the foregut endoderm and adjacent mesoderm, which costain posi-
tively for isl1 and Nkx2.5.
(C) Cells coexpressing Nkx2.5 and flk1 are found in differentiating myocardium and are indicated by pink arrows.the developing embryo, can be isolated, and maintain
their multipotentiality after clonal amplification in vitro.
A Single Isl1+ Progenitor Gives Rise to Three Distinct
Cardiovascular Cell Lineages
Based on the genetic fate mapping of embryonic isl1 heart
progenitors, as well as the multilineage differentiation and
transcriptional profiling of postnatal, ES-, and embryo-
derived isl1 cardiac precursors, we propose a working
model for a hierarchy of isl1+ cells that control lineage
specification in the second heart field (Figure 7J). A multi-
potent isl1+ progenitor cell (MICP) serves as a common
cardiovascular precursor for the three main lineages of
the developing heart. Toward cell-fate determination, this
cell expresses flk1 and Nkx2.5. Dual isl1+/flk1+ cells could
represent a subset of ‘‘vascular’’ downstream progenitors,
being able to convert into endothelial and smooth muscle
cells. Cardiac or smooth muscle lineages arise from
Nkx2.5-expressing cells, which can be either isl1+/flk1
or isl1/flk1+. Thus, both isl1+/Nkx2.5+/flk1 and isl1/1160 Cell 127, 1151–1165, December 15, 2006 ª2006 ElsevierNkx2.5+/flk1 populations would serve as more restricted
‘‘muscle’’ progenitors.
DISCUSSION
Spatial and Temporal Control of the Formation
of Endothelial, Cardiac, and Smooth Muscle Cell
Lineages for Diverse Heart Structures Occurs within
aSubsetof Isl1+Progenitors in theSecondHeart Field
Two distinct pools of cardiac progenitors originate from
the cardiogenic plate, the primary lineage, which differen-
tiates first, and a later differentiating population of cardiac
precursors, called the second lineage. The more dorsal/
medial localized second lineage takes a distinct migratory
path, which results in later arriving cells entering the form-
ing heart region from dorsal positions at the anterior and
posterior poles (Mjaatvedt et al., 2001; Waldo et al.,
2001; Brand, 2003). Isl1 marks this second population
(Cai et al., 2003), which is a major source of the cardiac
progenitors that contribute to the outflow tract, the rightInc.
Figure 7. Clonal Amplification of Embryo-Derived Cardiac Precursors on Cardiac CMC and Their Differentiation Analysis
(A–D) Representative clone of embryo-derived cardiac progenitors on CMC at day 3, after immunofluorescence analysis for the nuclear proteins isl1
(green) and Nkx2.5 (cyan) and the surface marker flk1 (red). Nuclei are visualized by Hoechst 33528 (blue). Short white arrows indicate triple-positive
cells and long pink arrows cells costaining positively for Nkx2.5 and flk1.
(E–H) Representative clone of embryo-derived cardiac progenitors after 6 days on CMC. Themajority of the cellscoexpress isl1 (green, F) andNkx2.5 (red, G).
(I) Triple immunofluorescence stain for markers of differentiated endothelial cells (CD31, red), cardiomyocytes (cTnT, green) and smooth muscle cells
(SM-MHC, cyan) on progenitor clones after 12 days in culture on CMC. Nuclei are detected by Hoechst 33528 (blue).
(J) Model of cellular hierarchy of cardiovascular progenitors and their lineage specification. See Discussion for details.Cell 127, 1151–1165, December 15, 2006 ª2006 Elsevier Inc. 1161
ventricle, portions of the left ventricle, and the atria, ana-
tomical structures, which are absent in mutant hearts of
isl1 homozygous knockout mice. In contrast, the first pop-
ulation of cardiac precursors give rise to the left ventricle
and parts of the atria (Buckingham et al., 2005). Retro-
spective clonal analysis in the mouse indicated that the
first and the second cardiogenic lineages may segregate
from one common primordial cell before the crescent
stage (Meilhac et al., 2004).
The early segregation of the two lineages, the different
time course of differentiation, and the distinct regional
contributions to the embryonic heart support the idea
that the two populations may have discrete properties.
In addition, the two pools of cardiac progenitors appear
to be governed by different genetic programs of self re-
newal and differentiation, which are in turn regulated by
distinct transcriptional networks, with Nkx2.5 as a critical
transcription factor in the first lineage and isl1, along
with Foxh1, GATA factors, and Hand2, as key regulators
in the second heart progenitor field (von Both et al.,
2004; Dodou et al., 2004). Lineage tracing studies indicate
that the first progenitor population has a more restricted
potential, generating the left ventricle and parts of the at-
ria, while the second lineage contributes to a greater diver-
sity of heart structures (Cai et al., 2003; Buckingham et al.,
2005; Verzi et al., 2005).
The question arises as to whether the initial specifica-
tion of the three major cell types within the heart, endothe-
lial, cardiac, and smooth muscle, actually originates in the
second heart lineage, and which are the cell populations
that act as cellular precursors for these distinct lineages.
The finding that isl1+ precursors in the second heart field
can contribute to muscle and nonmuscle cell lineages has
important implications for unraveling the pathways that
guide cardiac organogenesis (Ward et al., 2005). Previous
cell fate-mapping studies in avian systems have revealed
a common myogenic precursor that gives rise to both
working myocardium (atrial and ventricular muscle) and
the Purkinje cells of the conduction system (Gourdie
et al., 1998). The current study suggests that this precur-
sor is within the cellular hierarchy of isl1+ progenitors
and that it may be possible to isolate a unique subset of
precommitted SA nodal myocyte precursors from the
pool of isl1+ cardiogenic cells. In regard to the aorta and
pulmonary artery, it now emerges that isl1+ cells within
the second heart field lineage can account for a major
portion of the smooth muscle cells in the most proximal
outflow tract and their contribution appears to be indepen-
dent from the known requirement of the migrating cardiac
neural crest derivatives (Verzi et al., 2005; Waldo et al.,
2005). With respect to the coronary arterial system, the
current study indicates that the proepicardial organ is
not the only source of precursor cells originating this vas-
cular structure, as a significant portion of the proximal re-
gion seems to be derived from the isl1+ progenitors within
the second heart field. Finally, our results document that
the pool of second heart field isl1+ precursors contributes
to the endothelial cells within all of the heart components1162 Cell 127, 1151–1165, December 15, 2006 ª2006 Elsevier(endocardium, aorta, pulmonary, and coronary artery).
This would indicate a distinctly different origin for cardiac
endothelial lineages versus those of the peripheral vascu-
lature, which appear to be largely derived from hemangio-
blast precursors within the hematopoietic cell hierarchy
(Choi et al., 1998; Kouskoff et al., 2005).
AModel for Clonal Heart Cell Lineage Diversification
via Multipotency of Individual Isl1+ Cardiovascular
Progenitors
Since isl1+ progenitors in the second heart field can give
rise to endothelial, cardiac, and smooth muscle lineages,
we sought to determine if there might be a primordial
isl1+ cardiovascular stem cell that can account for all three
lineages. Previous evidence for a common vascular pro-
genitor arose from experiments with flk1+ mouse ES cells,
which were shown to differentiate into vascular smooth
muscle and endothelial cells upon injection into the chick
embryo or when analyzed under clonal conditions in vitro
(Yamashita et al., 2000; Ema et al., 2003). Retrospective
clonal studies utilizing an nlacZ reporter targeted to the
a-cardiac actin gene have documented in vivo a common
origin for precursor cells in the dorsal aorta and in the myo-
tome, which can differentiate into smooth muscle and
endothelium during development (Esner et al., 2006). Fur-
thermore, transcriptome-wide analysis of cardiac progen-
itors FACS-purified from transgenic Nkx2.5enhancer-eYFP
mouse embryos revealed an enriched expression of flk1
and tie2 transcripts, suggesting a shared identity between
cardiac crescent stage progenitors and vascular/hemato-
poietic (hemangioblasts) cell types (Masino et al., 2004). In
concordance, recent work in mouse ES cells identified
flk1+ precursors capable of differentiating into endothe-
lium and cardiac muscle in vitro (Iida et al., 2005; Yama-
shita et al., 2005).
In the current study, we describe the discovery of sin-
gle-cell derived clones of isl1+/Nkx2.5+/flk1+ precursors
(MICPs) that can spontaneously convert into endothelial,
cardiac, and smooth muscle cells. Taken together, these
findings suggest a working model for the initial framework
of the cellular hierarchy that governs lineage specification
in the second heart field (Figure 7J). In this model, isl1+
cells that eventually express Nkx2.5 and flk1 serve as pri-
mordial cardiovascular progenitors, which can give rise to
all three lineages, cardiac muscle, smooth muscle, and
endothelium. Since endothelial cells arose only from
clones containing precursors, which expressed isl1 and
flk1, the dual isl1-flk1 positive cells may represent a subset
of downstream progenitors that are more restricted in their
differentiating potential, being able to convert into endo-
thelial and smooth muscle cells. These results are in con-
cordance with previous studies suggesting that ES cell-
derived flk1+ cells can give rise to the two major vascular
cell types (endothelial and mural cells) in vitro and in vivo
(Yamashita et al., 2000). The isl1+/Nkx2.5+ are akin to the
postnatal isl1+ progenitors and could ultimately generate
either cardiac or smooth muscle lineages. Both muscle
lineages can also arise from cells that are only Nkx2.5+.Inc.
This finding and the recent study by Wu et al. (2006), in
combination with the evidence that the differentiation
event is associated with isl1 downregulation (Cai et al.,
2003: Laugwitz et al., 2005), suggest that the decision to
enter either the cardiac or smooth muscle cell program
is made at the level of precursors expressing Nkx2.5+.
This model of clonal heart-lineage diversification in isl1+
cardiovascular progenitors would be analogous to the he-
matopoietic stem-cell (HSC) model proposed by others
(Kiel et al., 2005), where a primordial single HSC can gen-
erate all of the blood-cell lineages. The single cell-level
decision also implies that there will be critical molecular
networks that not only act as positive regulators toward
a certain lineage but also repress entry into alternative
cell phenotypes.
Isl1+ Cardiovascular Progenitors and Molecular
Pathways for Congenital and Adult Heart Disease
Previous studies have shown that congenital heart dis-
ease due to mutations in the Nkx2.5 gene (Schott et al.,
1998) arises as a result of defects in cardiac lineage spec-
ification (Pashmforoush et al., 2004). Accordingly, a subset
of congenital heart diseases associated with abnormali-
ties in pivotal genes expressed within isl1+ cardiovascular
progenitors might be due to selective defects in the self re-
newal, differentiation, and lineage specification of distinct
tissue-restricted precursors. The availability of clonal-
based assay systems to study the generation of endothe-
lial, cardiac, and smooth muscle cell lineages from primor-
dial isl1+ cardiovascular progenitors is extremely valuable
in sorting out these pathways at a single cell level.
Recent experimental and clinical studies have under-
scored the need to identify the optimal cell type to drive
robust cardiac muscle regeneration for the failing heart
(for review, see Schwartz, 2006; Chien, 2004, 2006). While
embryonic stem cells have been suggested to be a renew-
able source of cardiac muscle cells for transplantation,
this has been problematic given the difficulty in generating
sufficient amounts of homogenous cardiac myocytes and
the dangers associated with the risk of teratomas (La-
flamme and Murry, 2005; Murry et al., 2005; Rubart and
Field, 2006). In this regard, the current study suggests
an alternative strategy for achieving the regeneration of
distinct heart components that are affected in diverse
forms of degenerative heart disease. The delivery of spe-
cific clonally derived cardiac progenitors from ES cells,
which represent tissue-restricted precursors limited in
their differentiation potential, may allow regeneration of
specific heart structures without the risks and limitations
of other ES cell-based systems.
EXPERIMENTAL PROCEDURES
Isolation and Cell-Culture Conditions of Mouse Postnatal
Cardiac Progenitors and CMC
To isolate cardiac progenitors, we used 40–60 hearts from 1–5 day-old
pups, which were double heterozygous for isl1-mER-Cre-mER and
R26R alleles and cultured the CMC, containing the majority of b-gal+
progenitor cells, as previously described (Laugwitz et al., 2005). 4-OH-Cell 1TM (Sigma) was applied in culture 1 day after cell plating at a concentra-
tion of 1mM and maintained for 2 days. CMC were isolated from CD1
wild-type mice and used as a mitomycin-treated feeder layer for ES
cells.
Differentiation of Postnatal Cardiac Progenitors into Smooth
Muscle Cells
For coculture, hca-SMC cells were plated at a density of 104/cm2 on
fibronectin-coated permanox chamber slides, using SMBM medium
(Cambrex). Twenty-four hours later, CMC from isl1-mER-Cre-mER/
R26R animals were FACS sorted after C12FDG labeling and b-gal
+ cells
were added to hca-SMC (53 103cells/cm2). After 1–5 days, cells were
stained for LacZ and SM-MHC. For spontaneous differentiation, FACS-
sorted b-gal+ cells were plated at a density of 104 cells/cm2 on fibro-
nectin-coated permanox chamber slides and cultured in Dulbecco’s
minimal essential media (DMEM)/F12 containing B27 supplement,
2% fetal bovine serum (FBS), and 10 ng/ml EGF (DMEM/F12 complete)
for 1–5 days, prior to immunostain for smooth muscle markers.
ES Cell Culture and Differentiation
Isl1-nLacZ knockin ES cells were generated by insertion of a loxP-
flanked nuclear lacZ SV40 pA cassette, followed by hrGFP and a neose-
lectable marker flanked by ferrotransferrin sites into Exon 1 of the
genomic isl1 locus (Y. Sun and S.M. Evans, submitted). ES cells were
maintained on mitomycin-treated embryonic feeders in DMEM medium
supplementedwith15%FBS (Hyclone), 2mML-glutamine,0.1 mM non-
essential amino acids,1 mM sodiumpyruvate, 0.1mMb-mercaptoetha-
nol, 100 U/ml penicillin, 100mg/ml streptomycin, and 0.1mg/ml LIF. Cells
were differentiated for 5 days as EBs formed in hanging drops of ES cell
medium without LIF. Five day EBs were dissociated into single cells with
0.25% trypsin for 5 min at 37C. For the isl1-nLacZ knockin ES cells,
dissociated cells were plated as single cell on top of mitomycin-treated
CMC or embryonic feeders at a density of 103 cells/cm2 in DMEM/F12
complete medium. Growing clones from single cells plated on CMC
were picked after 6–7 days coculture and trypsinized. Half of the cells
from each clone were used for RNA extraction and the rest was plated
into 3 wells of a 384-well plate for differentiation experiments. Differen-
tiation was triggered into myocytes, on fibronectin by using DMEM/
M199 (4:1 ratio) medium containing 10% horse serum and 5% FBS;
SM cells, on fibronectin by using DMEM/F12 complete medium; and
endothelial cells, on collagen IV by using DMEM supplemented with
10% FBS and 50 ng/ml mouse VEGF (R&D systems).
Isolation, Culture Amplification, and Differentiation
of Embryo-Derived Cardiac Precursor Cells
Tissue from the heart region of 60–100 wild-type embryos ED8.0–8.5
was digested with 470 U/ml collagenase type II (Worthingthon) in
HBSS for 30 min at 37C, followed by a 5 min treatment with 0.25%
trypsin. Dissociated cells were filtered through a 40 mm cell strainer
and plated on top of mitomycin-treated CMC at a density of 103
cells/cm2 in DMEM/F12 complete medium. For triggered differentia-
tion experiments and transcriptional profiling by RT-PCR, growing
clones from single cells plated on CMC were picked after 6–7 days
coculture, trypsinized, and processed as described above for the ES
cell-derived progenitor clones.
Supplemental Data
Supplemental data include Supplemental Experimental Procedures,
Supplemental Results, one figure, and two tables and can be found
with this article online at http://www.cell.com/cgi/content/full/127/6/
1151/DC1/.
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